Drug-Drug Interaction of Pyrotinib With a Moderate CYP3A Inducer

Clinical trial NCT04680091 · UNKNOWN

Trial details

NCT number: NCT04680091
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects, Drug-drug Interaction, Pyrotinib

Start date: 2020-11-12
Primary completion: 2021-01-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.